|
|
|
Out-of-Pocket Healthcare 2012
4/3/2012 | published by: Kalorama Information
Despite numerous attempts to reign in costs of healthcare, consumers are increasingly paying for healthcare products and services from their own monies. The costs of health care products and services continue
|
more...
|
$995.00
|
|
World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
3/1/2012 | published by: Kalorama Information
This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological drugs, describing the global market and identifying major market factors
|
more...
|
$3,995.00
|
|
Anti-Diabetic Pharmaceuticals Market in India 2012
3/30/2012 | published by: Netscribes (India) Pvt. Ltd.
Anti-diabetic pharmaceuticals market in India is one of the most lucrative diabetes markets in the world. Since India is the second largest diabetic pool in the world after China, the Indian market is characterized by
|
more...
|
$795.00
|
|
Anti-Infective Pharmaceuticals Market in India 2012
4/6/2012 | published by: Netscribes (India) Pvt. Ltd.
Anti-infective pharmaceuticals market in India is the largest contributor to domestic pharmaceutical sales, contributing around 18%. Since India has a huge patient pool, the Indian market is characterized by a huge demand for anti-infective drugs.
|
more...
|
$795.00
|
|
Pharmaceuticals in Turkey: ISIC 2423
3/1/2012 | published by: Euromonitor International
Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals market at a national level. It provides
|
more...
|
$600.00
|
|
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q2 2012
2/28/2012 | published by: Business Monitor International
|
more...
|
$530.00
|
|
Japan Pharmaceuticals and Healthcare Report Q2 2012
2/28/2012 | published by: Business Monitor International
|
more...
|
$1,175.00
|
|
Kazakhstan Pharmaceuticals and Healthcare Report Q2 2012
3/6/2012 | published by: Business Monitor International
BMI View: Kazakhstan remains the most accessible and competitive pharmaceutical market in Central Asia and the growing expectation it will gain World Trade Organisation (WTO) membership by the end of 2012 is driving continued regulatory
|
more...
|
$1,175.00
|
|
Oman Pharmaceuticals and Healthcare Report Q2 2012
3/6/2012 | published by: Business Monitor International
BMI View: Oman’s 2012 budget allocated a greater sum of money to the healthcare sector, in line with BMI’s view that the Arab spring would lead to greater spending in this segment. The Omani government
|
more...
|
$1,175.00
|
|
Zimbabwe Pharmaceuticals and Healthcare Report Q2 2012
3/6/2012 | published by: Business Monitor International
BMI View: On account of its unpredictable and unfavourable operating environment and limited funding for and investment in healthcare and medicines, Zimbabwe’s pharmaceutical market will remain unattractive to foreign companies for the foreseeable future. Poor
|
more...
|
$1,175.00
|
